Superscript III reverse transcriptase drug

Aliases

Superscript III

External links

DrugBank · PubChem

No related entities found.

Mentioned in (18)

Papers in which this entity is mentioned.

• Machine-guided design of cell-type-targeting cis-regulatory elements. (2024)
• Nanopore sequencing of RNA and cDNA molecules in . (2022)
• The role and robustness of the Gini coefficient as an unbiased tool for the selection of Gini genes for normalising expression profiling data. (2019)
• Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma. (2019)
• Sequence, Structure, and Context Preferences of Human RNA Binding Proteins. (2018)
• A fast detection of fusion genes from paired-end RNA-seq data. (2018)
• Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype. (2017)
• Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. (2016)
• A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. (2015)
• The landscape of long noncoding RNAs in the human transcriptome. (2015)
• PVT1 dependence in cancer with MYC copy-number increase. (2014)
• LIN28B promotes growth and tumorigenesis of the intestinal epithelium via Let-7. (2013)
• An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia. (2012)
• Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. (2012)
• Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. (2012)
• Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. (2011)
• Integrative analysis of the melanoma transcriptome. (2010)
• Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts. (2009)

Merged raw entities (2)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.